Carmell Secures Pipe Investment for Commercial Expansion
Carmell Corporation (Nasdaq: CTCX) recently closed a private placement, raising $1.85 million by issuing 8,065,210 shares of common stock...
eClinical Tech News
Capricor Submits Deramiocel BLA to FDA for Duchenne Muscular Dystrophy
Capricor Therapeutics has submitted a Biologics License Application (BLA) to the U.S. FDA for deramiocel, a cell therapy designed...
Neumora Therapeutics Reports Positive Navacaprant Data in MDD
Neumora Therapeutics announced Phase 3 trial results for its major depressive disorder (MDD) drug, navacaprant. The KOASTAL-1 study, the...
Firefly Neuroscience Secures $12.4M Financing
Firefly Neuroscience (NASDAQ: AIFF) secured up to $12.4 million in financing, consisting of $2.4 million in convertible notes and...
Hutchmed Divests Non-Core Joint Venture for US$608 Million
Hutchmed is divesting its 45% stake in Shanghai Hutchison Pharmaceuticals Limited (SHPL) for approximately US$608 million to GP Health...
Kala Bio’s $10.75M Private Placement: A Promising Opportunity?
Kala Bio, a clinical-stage biopharmaceutical company focused on eye diseases, secured approximately $10.75 million in a private placement involving...
Telix Pharma: Noble Registry Update: TLX599-CDX PSMA SPECT Imaging
Telix Pharmaceuticals and the Oncidium foundation announced positive initial results from the NOBLE Registry, a real-world evidence study of...
Ikena Oncology and Inmagene Merger Announcement
Ikena Oncology and Inmagene Biopharmaceuticals have entered into a definitive merger agreement. The combined company will focus on developing...
Holoclara Initiates Phase 1 HC002 Trial in Adults
Holoclara, a biotechnology company, has launched its first-in-human Phase 1 clinical trial for HC002, an orally available small molecule...
eClinical Solutions and Snowflake Partner for Life Sciences
eClinical Solutions and Snowflake have partnered to integrate eClinical’s elluminate Clinical Data Cloud with the Snowflake AI Data Cloud....